Laurus Labs Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is SACUBITRIL VALSARTAN 3NA COMPLEX, with a corresponding US DMF Number 33647.
Remarkably, this DMF maintains an Active status since its submission on June 07, 2019, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of August 06, 2019, and payment made on April 08, 2019, indicating their dedication to facilitating drug approvals, Categorized as Type II